To include your compound in the COVID-19 Resource Center, submit it here.

Avexa, Cytopia, Progen deal

Cytopia and a group of other Progen shareholders are seeking to replace Progen's board with a slate of three independent directors, merge the two

Read the full 241 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE